Allergan PLC (AGN)

Allergan PLC, adjusted current assets

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current assets
	Adjustments
	Add: Allowance for doubtful accounts
	Less: Current deferred tax assets1
	After Adjustment
	Adjusted current assets

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted total assets

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total assets
	Adjustments
	Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
	Add: Allowance for doubtful accounts
	Less: Current deferred tax assets2
	Less: Non-current deferred tax assets3
	After Adjustment
	Adjusted total assets

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted current liabilities

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current liabilities
	Adjustments
	Less: Current deferred tax liabilities1
	Less: Current deferred revenue
	Less: Current accrued product warranties
	Less: Current restructuring accrual
	After Adjustment
	Adjusted current liabilities

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted total liabilities

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Less: Current deferred tax liabilities2
	Less: Non-current deferred tax liabilities3
	Less: Deferred revenue
	Less: Accrued product warranties
	Less: Restructuring accrual
	After Adjustment
	Adjusted total liabilities

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted shareholders’ equity

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Shareholders’ equity
	Adjustments
	Less: Deferred taxes1
	Add: Allowance for doubtful accounts
	Add: Deferred revenue
	Add: Accrued product warranties
	Add: Restructuring accrual
	Add: Noncontrolling interest
	After Adjustment
	Adjusted shareholders’ equity

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted capitalization table

US$ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current portion of long-term debt and capital leases
	Long-term debt and capital leases, excluding current portion
	Total reported debt
	Shareholders’ equity
	Total reported capital
	Adjustments to Debt
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Adjusted total debt
	Adjustments to Equity
	Less: Deferred taxes2
	Add: Allowance for doubtful accounts
	Add: Deferred revenue
	Add: Accrued product warranties
	Add: Restructuring accrual
	Add: Noncontrolling interest
	Adjusted shareholders’ equity
	After Adjustment
	Adjusted total capital

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted net revenues

US$ in thousands

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net revenues
	Adjustments
	Add: Increase (decrease) in deferred revenue
	After Adjustment
	Adjusted net revenues

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Allergan PLC, adjusted net income (loss) attributable to shareholders

US$ in thousands

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net income (loss) attributable to shareholders
	Adjustments
	Add: Deferred income tax expense (benefit)1
	Add: Increase (decrease) in allowance for doubtful accounts
	Add: Increase (decrease) in deferred revenue
	Add: Increase (decrease) in accrued product warranties
	Add: Increase (decrease) in restructuring accrual
	Less: Income (loss) from discontinued operations, net of tax
	Add: Other comprehensive income (loss), net of tax
	Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
	After Adjustment
	Adjusted net income (loss) attributable to shareholders

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).